CME Group Inc
DUS:MX4A
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
C
|
CME Group Inc
DUS:MX4A
|
US |
|
T
|
TransAlta Corp
XMUN:TZ1
|
CA |
|
Hoya Corp
F:HYB0
|
JP |
|
Covivio SA
PAR:COV
|
FR |
|
M
|
Merck & Co Inc
XMUN:6MK
|
US |
|
I
|
Ionis Pharmaceuticals Inc
XMUN:ISI
|
US |
|
L'Oreal SA
F:LORA
|
FR |
|
American Resources Corp
NASDAQ:AREC
|
US |
Wall St Price Targets
MX4A Price Targets Summary
CME Group Inc
According to Wall Street analysts, the average 1-year price target for MX4A is 245.66 EUR with a low forecast of 196.09 EUR and a high forecast of 292.49 EUR.
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is MX4A's stock price target?
Price Target
245.66
EUR
According to Wall Street analysts, the average 1-year price target for MX4A is 245.66 EUR with a low forecast of 196.09 EUR and a high forecast of 292.49 EUR.
What is the Revenue forecast for CME Group Inc?
Projected CAGR
-6%
Over the last 13 years, the compound annual growth rate for Revenue has been 11%. The projected CAGR for the next 5 years is -6%.
What is the Operating Income forecast for CME Group Inc?
Projected CAGR
-8%
Over the last 13 years, the compound annual growth rate for Operating Income has been 14%. The projected CAGR for the next 5 years is -8%.
What is the Pre-Tax Income forecast for CME Group Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Pre-Tax Income has been 9%. The projected CAGR for the next 3 years is 7%.
What is the Net Income forecast for CME Group Inc?
Projected CAGR
7%
Over the last 13 years, the compound annual growth rate for Net Income has been 12%. The projected CAGR for the next 5 years is 7%.
